SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

Background Proliferation markers and profiles have been recommended for guiding the choice of systemic treatments for breast cancer. However, the best molecular marker or test to use has not yet been identified. We did this study to identify factors that drive proliferation and its associated fea...

Full description

Bibliographic Details
Main Authors: Abdel-Fatah, Tarek M.A., Agarwal, Devika, Liu, Dong-Xu, Russell, Roslin, Rueda, Oscar M., Liu, Karen, Xu, Bing, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Rees, Robert C., Caldas, Carlos, Ellis, Ian O., Ball, Graham R., Chan, Stephen Y.T.
Format: Article
Language:English
Published: Elsevier 2016
Online Access:http://eprints.nottingham.ac.uk/37734/
http://eprints.nottingham.ac.uk/37734/
http://eprints.nottingham.ac.uk/37734/
http://eprints.nottingham.ac.uk/37734/1/THELANCETONCOLOGY-D-15-01510R4.pdf

Internet

http://eprints.nottingham.ac.uk/37734/
http://eprints.nottingham.ac.uk/37734/
http://eprints.nottingham.ac.uk/37734/
http://eprints.nottingham.ac.uk/37734/1/THELANCETONCOLOGY-D-15-01510R4.pdf

Similar Items